The first step in splicing of pre-mRNAs with long introns is exon definition, where U1 and U2 snRNPs bind at opposite ends of an exon. After exon definition, these snRNPs must form a complex across the upstream intron to allow splicing catalysis. Exon definition and conversion of cross-exon to cross-intron spliceosomal complexes are poorly understood. Here we demonstrate that, in addition to U1 and U2 snRNPs, cross-exon complexes contain U4, U5, and U6 (which form the tri-snRNP). Tri-snRNP docking involves the formation of U2/U6 helix II. This interaction is stabilized by a 5 0 splice site (SS)-containing oligonucleotide, which can bind the tri-snRNP and convert the cross-exon complex into a cross-intron, B-like complex. Our data suggest that the switch from cross-exon to cross-intron complexes can occur directly when an exon-bound tri-snRNP interacts with an upstream 5 0 SS, without prior formation of a cross-intron A complex, revealing an alternative spliceosome assembly pathway.
INTRODUCTION
Pre-mRNA splicing is catalyzed by the spliceosome, which catalyzes intron removal, and exon ligation to form mature mRNA. The spliceosome consists of the U1, U2, U4/U6, and U5 snRNPs and a multitude of other splicing factors . When introns are relatively short (less than $200 nt), spliceosomes assemble first across the intron (Fox-Walsh et al., 2005) . Thus, U1 base pairs with the 5 0 splice site (SS) of the pre-mRNA to form the E complex, and U2 then interacts stably with the branchpoint sequence (BPS) to form the A complex. Subsequent recruitment of the U4/U6.U5 tri-snRNP generates the B complex. Major conformational and compositional rearrangements follow. At the 5 0 SS, U1 base pairing is replaced by interaction of U6 via its ACAGAG box. Subsequently, U4 dissociates from U6, and the latter base pairs with U2 (Nilsen, 1998) . After release of U1 and U4, the activated B* complex is formed. It catalyzes step 1 of splicing, during which the 5 0 SS is cleaved and the intron's 5 0 end is ligated to the branch adenosine. This generates the C complex, which catalyzes step II of splicing, during which the intron is excised and the 5 0 and 3 0 exons are joined. Most mammalian introns span more than 200 nt (Deutsch and Long, 1999) , whereas exons have a rather fixed length of only $120 nt on average (Ast, 2004) . When a pre-mRNA contains a long intron, initial splicing complex formation occurs across an exon, a process called exon definition (Berget, 1995) . During the latter, U2 binds the BPS upstream of the exon and U1 the 5 0 SS downstream of it. Splicing enhancer sequences within the exon (ESEs) recruit SR proteins that establish a network of protein-protein interactions across the exon, thereby bridging U2 and U1 and stabilizing the exon-defined complex (Hoffman and Grabowski, 1992; Reed, 2000) . As the chemical steps of splicing occur across an intron, subsequent to exon definition the 3 0 SS must be paired with an upstream 5 0 SS across the adjacent intron. Thus, it is thought that cross-exon interactions are disrupted and the cross-exon complex is converted into a cross-intron A complex, where a molecular bridge now forms between U2 and U1 bound to an upstream 5 0 SS (Reed, 2000) . This step is decisive in determining which 5 0 and 3 0 exon will ultimately be spliced together; recent data indicate that regulation of exon inclusion or skipping occurs during the switch from a cross-exon to cross-intron complex (Bonnal et al., 2008; House and Lynch, 2006; Sharma et al., 2008) . Although splice site pairing was shown to occur during A complex formation (Lim and Hertel, 2004) , it is not known how long the cross-exon molecular interactions persist and whether they must be disrupted to allow cross-intron complex formation. In current models, the tri-snRNP first binds after exon definition, interacting with the cross-intron A complex, thereby generating a B complex.
Dissection of the swap between cross-exon and cross-intron interactions has proven difficult, due to the inability to form solely a cross-exon complex on single or multiple intron pre-mRNAs and then chase it into a cross-intron complex. However, transsplicing, where the 5 0 SS and 3 0 SS are present on physically distinct molecules, appears to provide an alternative to mimic the conversion from a cross-exon to cross-intron complex. During trans-splicing, an A-like complex, in which the U2 snRNP is stably bound to the 3 0 SS and U1 to a downstream 5 0 SS, is assembled on single exon constructs (Grabowski et al., 1991; Robberson et al., 1990) . Upon addition of a short 5 0 SS-containing RNA oligonucleotide (oligo) to these cross-exon complexes, a B-like complex that can be resolved on native gels is formed, and splicing in trans to the 5 0 SS RNA is observed (Ast et al., 2001; Konforti and Konarska, 1995) . In this system, the U1 snRNP/ 5 0 SS interaction is bypassed, with the 5 0 SS RNA oligo binding directly to the ACAGAG box of the U6 snRNA (Konforti and Konarska, 1994) . In current trans-splicing models, the trisnRNP first interacts with the 5 0 SS RNA oligo and subsequently with complexes formed on the 3 0 exon to form splicing-competent spliceosomes. A detailed dissection of the conversion of splicing complexes formed on a single exon construct to a B-like complex might provide insights into the switch from an exon-defined complex to one in which the splice sites are paired across the intron, as occurs during cis-splicing.
To learn more about exon definition and the conversion of a cross-exon to a cross-intron splicing complex, we purified cross-exon complexes formed in vitro. Our studies unexpectedly reveal that U4/U6.U5 tri-snRNPs associate already during exon definition. Tri-snRNPs, as part of purified cross-exon complexes, can bind a 5 0 SS-containing RNA oligo, which in turn stabilizes tri-snRNP association and converts the exon complex into a B-like spliceosomal complex. Our results indicate that cross-exon complexes containing the tri-snRNP can directly engage an upstream 5 0 SS and thereby lead to the pairing of splice sites across an intron.
RESULTS

Cross-Exon A-like Complexes Form on a MINX Single Exon Construct
To investigate exon definition in more detail, we constructed a derivative of the MINX pre-mRNA substrate, which contains exon 2 flanked upstream by an anchoring site (AS)-a stretch of $25 nucleotides upstream of the BPS that are recognized in a sequence-unspecific manner by U2-SF3a/b subunits-the BPS, polypyrimidine tract, and 3 0 SS ( Figure 1A ; see also Figure S1 available online). Downstream of the exon, a 5 0 SS and three MS2 loops for affinity purification are present. Upon incubation of this MINX exon RNA with HeLa nuclear extract under splicing conditions for 3 min, a complex comigrating with the cross-intron A complex (formed on MINX pre-mRNA) was detected in native gels after heparin treatment ( Figure 1B) . No significant increase in these cross-exon complexes was observed after 5 min, indicating that they form efficiently within 3 to 5 min. Similar results were also obtained with a MINX exon RNA lacking MS2 aptamers ( Figure S1 ). Consistent with previous results, formation of cross-exon A-like complexes (hereafter termed exon complexes) was ATP dependent and was greatly reduced upon depletion of U1 or U2 snRNPs from nuclear extract ( Figure S1 ) (Ast et al., 2001; House and Lynch, 2006; Konforti and Konarska, 1995; Robberson et al., 1990) .
The U4/U6.U5 Tri-snRNP Is Present in Affinity-Purified Exon Complexes We next affinity purified complexes formed on the MINX exon RNA. After allowing exon complexes to form, splicing reactions were subjected to glycerol gradient centrifugation. Two peaks containing the 32 P-labeled exon RNA were observed, a minor one peaking in fraction 11 and a major one in fraction 15, with S values of 23 and 37, respectively ( Figure 1C ; see also Figure S1 for MINX exon RNA lacking MS2 sites). In the absence of ATP, solely 23S complexes were observed ( Figure 1C ). Complexes were then purified by MS2 affinity selection. 23S complexes contained similar amounts of the exon and U1 and U2 RNA-even in the absence of ATP ( Figure 1D and data not shown). Thus, this peak likely contains A-like complexes plus some E-like and H complexes. Surprisingly, 37S complexes contained nearly equimolar amounts of not only exon RNA, U1, and U2, but also U4, U5, and U6 snRNA ( Figure 1D ), indicating that the tri-snRNP also associates with cross-exon complexes. Tri-snRNPs were also found in exon complexes formed on a b-globin exon construct (see below) and on the BSEx4 RNA ( Figure S1 )-containing exon 4 from the c-src pre-mRNA (Sharma et al., 2008) -indicating that their presence in exondefined complexes is not limited to the MINX construct. Similar results (i.e., the presence of the tri-snRNP in the exon complex) were also observed via immunoprecipitation of 37S complexes formed on MINX exon RNA lacking MS2 aptamers ( Figure S1 ). Thus, as solely an A-like complex was detected in native gels, tri-snRNP association with the exon complex does not appear to withstand the stringent conditions (e.g., presence of heparin) of native gel electrophoresis.
To test whether tri-snRNP association is influenced by ESEs, we analyzed complex formation on an exon RNA containing a portion of exon 2 of the human b-globin gene and three welldefined ESEs designed by ESEfinder to bind the SRp55 protein ( Figure 2A ). This b-globin exon is alternatively spliced in vitro and in vivo in an ESE-dependent manner (Labourier et al., 1999 ). An A-like exon complex also formed on the b-globin construct (Figure 2B) , although less efficiently than the MINX A-like complex. Upon mutation of the 5 0 SS, complex formation was reduced, and after mutation of all ESEs ( Figure 2B ), it was nearly abolished. Thus, the ESEs play a more prominent role than the downstream 5 0 SS in stabilizing U2 binding during exon definition. Mainly 23S complexes formed on the b-globin exon RNA, with a small shoulder of complexes at 37S (data not shown). b-globin cross-exon complexes affinity purified from the 37S shoulder contained equimolar amounts of U1, U2, U4, U5, and U6 and exon RNA ( Figure 2C ). Upon mutation of the ESEs, the 37S shoulder was reduced (data not shown), and the remaining 37S complexes contained only residual amounts of U2, U4, U5, and U6 but an unchanged level of U1 relative to the ''wild-type'' construct ( Figure 2C ). The presence of equal amounts of U1 in both complexes, but at the same time reduced levels of U4, U5, and U6 snRNAs in the DESE complex, suggests that U1 bound to the downstream 5 0 SS is not sufficient for tri-snRNP recruitment.
A 5
0 SS Is Neither Necessary Nor Sufficient for Tri-snRNP Association To investigate the requirements for tri-snRNP recruitment, we mutated the 5 0 SS of the MINX exon construct to inhibit U1 snRNP binding. With this mutant, 23S complexes increased, whereas the 37S peak was now visible only as a shoulder
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Tri-snRNPs Associate with Cross-Exon Complexes glycerol gradient centrifugation. The radioactivity contained in each gradient fraction was determined as in (C).
(F) Complexes in the 20S peak (fractions 9-11) of (E) were purified and their RNA composition analyzed as in (D).
Tri-snRNPs Associate with Cross-Exon Complexes ( Figure 1C ). Analysis of purified 37S complexes revealed that although the level of U1 was substantially reduced, nearly equimolar amounts of exon RNA, U2, U4, U5, and U6 were still present ( Figure 1D ). Similar results were obtained with a 2 0 OMe oligo against the 5 0 end of U1 ( Figure S1 ). Thus, tri-snRNP recruitment does not strictly require a U1/5 0 SS interaction. Although the amount of 37S complex was reduced when U1 binding was blocked, this is likely an indirect effect due to reduced U2 snRNP binding-i.e., U1 enhances U2 association with single exon RNAs ( Figure S1 ; Robberson et al., 1990) .
When all intron nucleotides upstream of the exon were deleted (designated MINX DBPS exon RNA), solely 23S complexes ( Figure 1E ) that contain equimolar amounts of DBPS exon RNA and U1, plus lower amounts of U2, but no U4, U5 or U6, were observed ( Figure 1F ). Thus, a 5 0 SS plus adjacent exon is not sufficient for tri-snRNP association. The presence of U2 indicates it can still loosely associate presumably via weak interactions with the U1 snRNP. Taken together, these results indicate that tri-snRNP association is not mediated by the 5 0 SS or U1 snRNP.
U6 Base Pairs with U2 and U4 in the Exon Complex
Association of tri-snRNP with cross-intron B complexes involves a base-pairing interaction between the 5 0 end of U2 and the 3 0 end of U6 (i.e., U2/U6 helix II) (Nilsen, 1998) . To test whether this interaction is also formed in exon complexes, we performed psoralen crosslinking. MS2 affinity-purified MINX exon complexes were irradiated at 365 nm in the presence of psoralen, and crosslinks were analyzed by northern blotting ( Figure 3A) . A signal from the 32 P-labeled exon RNA could be detected without the addition of any probe. In the absence of psoralen, essentially no additional bands were detected. Upon hybridization of probes against the exon RNA or U1, U2, U4, or U6 snRNA, (lanes 7-9) were analyzed on native gels as described in Figure 1B .
(C) Cross exon complexes formed on b-globin ESE RNA also contain tri-snRNPs. Splicing reactions performed with b-globin ESE exon RNA were subjected to glycerol gradient centrifugation.
Complexes sedimenting in the 37S region of the gradient were pooled and affinity selected, and their RNA was analyzed as in Figure 1D .
several slower-migrating bands representing RNA-RNA crosslinks were observed in the presence of psoralen. For example, a very slowly migrating band was observed with the U1 probe (lane 7). The same band was also observed with the exon RNA probe but no other snRNA probe (lane 4). This demonstrates crosslink formation between the exon RNA and U1 snRNA, consistent with a U1/5 0 SS interaction ( Figure 3B ). Similarly, a crosslink between U2 and exon RNA was also observed, confirming a U2/BPS base-pairing interaction. Significantly, we could not detect any direct interaction of U6 with the MINX exon RNA, which would be expected if U6 base paired with the 5 0 SS. In contrast, a crosslink between U6 and U2 was clearly visible (lanes 11 and 13); note that the signal from the exon RNA in this region is likely due to internal crosslinks, as crosslinked, naked exon RNA migrates in this region ( Figure 3 , lane 5). Based on its migration behavior (Hausner et al., 1990) and also its presence in HeLa nuclear extract (lane 14), this U2/U6 crosslink indicates formation of U2/U6 helix II. A U4/U6 crosslink was also observed, suggesting that the U2/U6 interaction can occur without disrupting U4/U6 base pairing. Indeed, triple crosslinks were detected between the exon RNA, U2, and U6, and between U2, U6, and U4, indicating that these interactions take place simultaneously within the same complex. Thus, within the exon complex, U6 is base paired to U4 but also establishes initial contacts with U2, which is stably bound to the BPS of the exon RNA ( Figure 3B ). These data demonstrate that the tri-snRNP docks to the exon complex, at least in part by interacting with U2 when it is stably bound to the BPS.
Addition of a 5
0 SS RNA Oligo Generates a Heparin-Resistant B-like Complex To test whether addition of a 5 0 SS-containing RNA oligo can convert the MINX cross-exon complex into a stable B-like complex, we performed splicing in the presence of a 16 nt RNA oligo that contains an optimized 5 0 SS ( Figure 4A ). On native gels, a complex migrating similarly to the cross-intron B complex ( Figure 4B ) was observed after 5 min upon addition of a 100-fold
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Tri-snRNPs Associate with Cross-Exon Complexes molar excess of the 5 0 SS RNA oligo, but not with a 5 0 SS RNA oligo containing a mutated 5 0 SS ( Figure 4B ). Similar results were obtained with the b-globin exon and BSEx4 RNAs (Figure S1 and data not shown). Consistent with previous data (Konforti and Konarska, 1994) , affinity-purified B-like complexes contained the 5 0 SS RNA oligo ( Figure S2 ). Structure probing studies and the addition of a 2 0 OMe oligo against the U6 ACAGAG box indicated that the 5 0 SS RNA oligo interacts with the U6 ACAGAG box in our B-like complexes and that this interaction is required for stable tri-snRNP association (Figure S2) . Thus, heparin-resistant tri-snRNP binding occurs after initial association with the exon complex if the tri-snRNP subsequently interacts with a 5 0 SS in trans. The exon complex was still converted with similar efficiency into a B-like complex even when an excess of unlabeled competitor exon RNA was added together with the 5 0 SS oligo ( Figure 4C ). This demonstrates that the exon complex can be chased into the B-like complex (i.e., it is a precursor of the B-like complex).
Sedimentation analysis of complexes formed in the presence of the 5 0 SS RNA revealed an additional peak at $50S ( Figure 4D ). Affinity-purified 50S complexes contained similar molar amounts of exon RNA and all five U snRNAs (except for U1, which appeared to be slightly less abundant) ( Figure 4E ), confirming that they represent the B-like complexes observed on native gels. The reduced levels of U1 likely are due to the fact that excess 5 0 SS RNA competes with the exon RNA for U1 binding.
Complexes Formed on the MINX Exon RNA Support the Catalytic Steps of Splicing
The conversion of MINX cross-exon complexes to a B-like complex indicates that our cross-exon complexes are functionally competent for subsequent steps of spliceosome assembly. To test whether they also support the catalytic steps of splicing, we assayed for trans-splicing after incubating for 60 min under splicing conditions with unlabeled MINX exon RNA (lacking MS2 aptamers) and a 32 P-3 0 -endlabeled 5 0 SS RNA oligo as previously described by Konforti and Konarska (1995) . Significantly, three major radiolabeled bands were observed solely when both the 32 P-labeled 5 0 SS RNA oligo and exon RNA were present ( Figure 4F , lanes 1 and 2). Based on their migration behavior, the upper two bands appear to represent trans-splicing intermediates (5 0 SS RNA oligo intron sequences covalently linked to the branch adenosine of the MINX exon RNA), where the faster-migrating band most likely lacks the downstream intron part due to usage of the 5 0 ss of the MINX Exon RNA in an independent splicing reaction. In contrast, the lower band likely represents one of the
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Tri-snRNPs Associate with Cross-Exon Complexes trans-splicing products (i.e., spliced out branched intron). The identity of these bands was confirmed by performing RNase H digestions. Consistent with them containing exon RNA, both of the upper bands, but not the lower one, were hydrolysed in the presence of a DNA oligo complementary to nucleotides of the MINX exon, but not when a control oligo was added ( Figure 4F , lanes 3 and 4). Due to their low abundance, reliable sequence information after PCR amplification could not be obtained for the trans-spliced RNAs, nor could the branch site be mapped by primer extension. Nonetheless, these data indicate that at least a small subset of our B-like complexes are catalytically active.
Addition of the 5
0 SS Oligo to Purified Exon Complexes Stabilizes Tri-snRNP Association The studies described above were performed in nuclear extract, and thus it is possible that during B-like formation the tri-snRNP first interacts with the 5 0 SS RNA oligo prior to its stable association with the exon complex ( Figure 5A ). To test whether the tri-snRNP can bind the 5 0 SS RNA after it associates with the exon complex, we first affinity selected MINX cross-exon complexes. After washing complexes bound to amylose beads with low-salt (65 mM NaCl) buffer, we added the 5 0 SS RNA. We then assayed for stable tri-snRNP association by washing the matrix-bound complexes with buffer containing 300 mM NaCl. Complexes were then eluted and their RNA composition analyzed. As expected, in the absence of the 5 0 SS RNA oligo, the eluted exon complexes contained nearly equimolar amounts of all five U snRNAs and the exon RNA when the second wash buffer contained 65 mM NaCl ( Figure 5B, lane 1) . At 300 mM NaCl, most of U4, U5, and U6 were lost ( Figure 5B, lane 2) . Upon addition of the 5 0 SS RNA, but not the mutated 5 0 SS oligo, complexes washed with 300 mM NaCl still contained similar molar amounts of U1, U2, U4, U5, U6, and exon RNA ( Figure 5B , lanes 3 and 4), indicating that tri-snRNP association was stabilized after binding the 5 0 SS RNA. This indicates that the 5 0 SS RNA interacts directly with tri-snRNPs already bound to the exon complex and that all factors required for tri-snRNP stabilization are associated with purified exon complexes. Our data, in turn, suggest that the conversion of a cross-exon to cross-intron 
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Tri-snRNPs Associate with Cross-Exon Complexes complex (as mimicked here by formation of the B-like complex) does not require initial association of the tri-snRNP with an upstream 5 0 SS prior to its association with U2 bound to a downstream BPS.
Protein Composition of the Exon and B-like Complexes
We next determined the protein composition of the affinitypurified, 37S MINX exon complexes and 50S B-like complexes by performing liquid chromatography-tandem mass spectrometry (LC-MS/MS). Consistent with its snRNA composition, nearly all proteins of the U1, U2, and U4/U6.U5 snRNPs were found in exon complexes (Table 1 ). In addition, multiple nonsnRNP proteins were detected (Table 1 and Table S1 ). The vast majority of proteins previously detected in MS2 affinity-purified, human cross-intron A complexes were also found in our crossexon complexes (Table 1 and Table S1 ). In contrast, many nonsnRNP proteins previously found in affinity-purified B complexes were completely absent or present in lower amounts in the exon complex. For example, components of the hPrp19/CDC5 complex, which plays a crucial role during spliceosome activation (Chan et al., 2003) , and hPrp19-related proteins were either underrepresented or absent in cross-exon complexes, based on sequenced peptide numbers (Table 1) or additionally on the results of western blot analyses with antibodies against Prp19, Prl1, AD002, hRBM22, hSyf1, and hSyf3 ( Figure 6A ).
The vast majority of proteins present in the affinity-purified exon complexes were also found in the B-like complex (Table 1 and  Table S1 ). In contrast, several proteins appeared to be more abundant in the B-like complex or first recruited during B-like complex formation. These included (1) hSnu23 and hPrp38, which are are also found in human cross-intron B complexes (Table 1 and Figure 5A ); (2) Npw38 and Npw38BP, which copurify with the human Prp19/CDC5 complex; and (3) the ''B complex proteins'' UBL5, MFAP1, RED, and hSmu-1 (Table 1) . Proteins of the hPrp19/CDC5 complex were also more abundant in the B-like complex as compared to exon complex (Table 1 and Figure 6A ), but their levels, as well as those of Prp19-related proteins, were still lower than those observed in cross-intron B complexes (Table  1 and Figure 6A ). In summary, exon and B-like complexes have distinct proteomes, with the B-like complex compositionally more similar to the cross-intron B complex.
Addition of the 5
0 SS RNA Oligo Leads to Phosphorylation of hPrp31 and hPrp6 Phosphorylation of hPrp6 and hPrp31, both tri-snRNP components, occurs concomitant with cross-intron B complex formation and is mediated by hPrp4 kinase (Schneider et al., 2010) . As this kinase is present in both exon and B-like complexes, we assayed the phosphorylation status of hPrp6 and hPrp31. Western blotting with antibodies specific for phosphorylated hPrp6 or hPrp31 revealed that these proteins are phosphorylated upon addition of the 5 0 SS RNA oligo-but not the mutated 5 0 SS oligo or a 2 0 Ome RNA oligo against the U6 ACAGAG box-to affinity-purified exon complexes (Figure 6B) . Similar results were observed when the B-like complex was generated in the presence of nuclear extract (data not shown). In contrast, in the absence of exon RNA, addition of the 5 0 SS RNA oligo to nuclear extract, and subsequent incubation under splicing conditions, did not lead to any detectable phosphorylation of hPrp6 or hPrp31 (data not shown). Thus, hPrp6 and hPrp31 are also modified upon stable integration of the tri-snRNP after its association with the exon complex.
DISCUSSION
Here we have affinity purified cross-exon complexes formed during exon definition and demonstrate that they contain the U4/U6.U5 tri-snRNP. The requirements for tri-snRNP recruitment to the exon complex were further dissected, revealing a role for U2, which involved the formation of U2/U6 helix II. Tri-snRNP association with purified exon complexes was stabilized upon addition of a 5 0 SS-containing RNA in trans, suggesting that also during cis-splicing the tri-snRNP can interact with an upstream 5 0 SS after its association with an exon-defined complex. Our data thus provide insights into a potential assembly pathway of spliceosomes generated initially via exon definition.
The U4/U6.U5 Tri-snRNP Interacts with Exon Complexes during Exon Definition
Tri-snRNP association during exon definition was an unexpected finding, as previous MS2 affinity-selected cross-exon complexes formed on exon 4 of the c-src pre-mRNA (BSEx4) Figure 1D .
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Proteins identified by LC-MS/MS after separation by PAGE in at least two of three preparations are shown. Note that only a subset of proteins identified are shown here, with the remainder shown in Table S1 . Proteins not reproducibly detected are summarized in Table S2 . Proteins generally accepted to be common contaminants, such as ribosomal proteins, are not shown. The presence of a protein is indicated by a number which represents the absolute number of peptides sequenced for that protein in a particular preparation (i.e., #1, #2, #3, or #4). A ''+'' represents the presence of a protein in purified human A (Behzadnia et al., 2007) or B (Deckert et al., 2006) complexes. Proteins are grouped in organizational and/or functional subgroups.
Tri-snRNPs Associate with Cross-Exon Complexes contained solely U1 and U2 snRNPs (Sharma et al., 2008) . However, in our hands, tri-snRNPs also interacted with BSEx4, as well as a b-globin exon RNA, indicating that their presence is a more general phenomenon. Addition of the 5 0 SS oligo to purified exon complexes stabilized tri-snRNP association and also triggered phosphorylation of the tri-snRNP proteins Prp6 and Prp31 (Figure 6 ), modification events that also accompany stable association of the tri-snRNP during cross-intron B complex formation (Schneider et al., 2010) . Stabilization of tri-snRNP association also led to the recruitment of a subset of proteins specifically or predominantly associating first during the conversion of a cross-intron A complex to B complex. Finally, complexes formed on the MINX exon RNA catalyzed transsplicing after addition of the 5 0 SS oligo. However, as the effi- ciency of trans-splicing was quite low, we cannot rule out that a small subpopulation of complexes, not related to the B-like complex, are responsible for this catalytic activity. Taken together, these results suggest that the tri-snRNP is associated in a functional manner with the exon complex. Whether the trisnRNP associates concomittantly with the U1 and U2 snRNPs during exon complex formation is not clear. A 23S exon complex containing solely U1 and U2 is detected in glycerol gradients, consistent with the idea that it may be a precursor of the exon complex that additionally contains the tri-snRNP. However, additional experiments are needed to clarify this point.
Recruitment of the Tri-snRNP to the Exon Complex Occurs via the U2 snRNP U2, as opposed to U1, plays a key role in recruiting the tri-snRNP to the exon complex. In complexes where U1 binding is unaltered but U2 no longer stably binds (i.e., MINX DBPS exon RNA or b-globin DESE RNA), tri-snRNP association is completely abolished (Figures 1 and 2) . Psoralen crosslinking demonstrated that the U6 snRNA base pairs with U2 (forming U2/U6 helix II) within the cross-exon complex (Figure 3) , confirming a direct interaction between U2 and a tri-snRNP subunit. Additional contacts involved in tri-snRNP docking are presently not known but likely include protein-protein interactions. Indeed, recruitment of the tri-snRNP to the cross-intron A complex is mediated by several proteins that are also found in purified cross-exon complexes, including SR proteins (Roscigno and Garcia-Blanco, 1995) and the U2-associated SPF30 protein (Meister et al., 2001) .
The association of the tri-snRNP with purified exon complexes was stabilized upon addition of a 5 0 SS RNA that binds the ACAGAG box of the U6 snRNA. 5 0 SS binding thus appears
Tri-snRNPs Associate with Cross-Exon Complexes to induce a conformational/compositional change that leads to/ enables stable tri-snRNP association with the U2 snRNP and possibly other components of the exon complex. Binding of the 5 0 SS RNA oligo induces phosphorylation of hPrp6 and hPrp31, and it is likely that this phosphorylation event stabilizes contacts between these tri-snRNP proteins and other components of A or exon complexes.
The Proteome of Exon and B-like Complexes
Exon complexes contained essentially all snRNP proteins, plus numerous non-snRNP spliceosomal proteins (Table 1 and  Table S1 ). The protein composition of complexes formed on exon 4 of the c-src pre-mRNA, which contained solely the U1 and U2 snRNPs, was recently reported (Sharma et al., 2008) . Nearly all of the proteins detected by MS in this cross-exon complex were also found in our complexes; thus these shared proteins appear to be ''core'' components of exon complexes. The vast majority of proteins detected in affinity-purified, cross-intron A complexes (Behzadnia et al., 2007) were also found in our cross-exon complexes. Unexpectedly, there did not appear to be any obvious candidates for proteins that associate solely with exon complexes.
A relatively small number of proteins are recruited to the exon complex upon its conversion to a B-like complex. These include MFAP1, RED, hSmu-1, and UBL5, which are also recruited during formation of the human cross-intron B complex. Homologs of these proteins are not found in the budding yeast S. cerevisiae, where alternative splicing events are essentially nonexistent. Thus, they may be involved in regulated splicing events in higher eukaryotes. Interestingly, UBL5 in S. pombe is required for splicing and interacts with Snu66, a component of the tri-snRNP (Wilkinson et al., 2004) . Thus, this protein could potentially help recruit the tri-snRNP to the exon complex. hSnu23 was detected in the stabilized B-like complex, but not in the exon complex, and hPrp38 appeared to be more abundant in the former. hSnu23 and hPrp38 are present in the yeast but not human tri-snRNP (Gottschalk et al., 1999) but are also found in human cross-intron B complexes. Thus, they may also be involved in stabilizing the tri-snRNP interaction with the exon complex.
The protein compositions of the B-like and cross-intron B complex were very similar, but notable differences exist such as the absence or underrepresentation of components of the hPrp19 complex and Prp19-related proteins in the B-like complex (Table 1 and Figure 6 ). The less stable association of these proteins suggests that the B-like complex represents an earlier stage of spliceosome assembly compared to the B complex. Alternatively, the molecular organization of the B-like complex might generally differ somewhat from the B complex, as it was directly generated from a cross-exon complex, whereas the cross-intron B complex is generated from a cross-intron A complex. Although it is the product of a splicing reaction in which the 5 0 SS is added in trans, the B-like complex may be more representative of the majority of spliceosomes whose assembly is initiated by the formation of a cross-exon complex during exon definition.
Recent data from our lab demonstrate a crucial role for human Prp4 kinase during tri-snRNP integration into cross-intron B complexes (Schneider et al., 2010) . The fact that hPrp6 and hPrp31 are phosphorylated when affinity-purified cross-exon complexes are incubated with the 5 0 SS RNA oligo further supports the idea that they are phosphorylated directly by hPrp4 kinase in B and B-like complexes, as this kinase is detected in both complexes (Table 1 ). This further suggests that base pairing of the U6 ACAGAG box with the 5 0 SS in some unknown way triggers this phosphorylation event.
Insights into the Conversion from Cross-Exon to Cross-Intron Complexes Although pre-mRNA splicing normally involves splice sites present in cis, the trans-splicing system used here to generate B-like complexes nonetheless provides insights into a possible pathway for the conversion of cross-exon to cross-intron splicing complexes. Indeed, it is difficult to study this transition using pre-mRNA substrates in which exons are physically linked, as splicing snRNPs/factors will assemble simultaneously on different regions of the pre-mRNA. During exon definition, both ends of the exon are recognized in a coordinated manner, with factors binding the 3 0 SS (i.e., U2, U2AF) communicating (in many cases via SR protein-bound ESEs) with factors bound to the downstream 5 0 SS (i.e., U1) (Berget, 1995; Robberson et al., 1990) . In current models, the next assembly step entails that contacts across an exon be broken to allow new contacts across the intron between the 3 0 SS (bound by U2) and upstream 5 0 SS (bound initially by U1) (Robberson et al., 1990) . Afterwards, the tri-snRNP is proposed to bind the cross-intron A complex, forming the B complex. Subsequently, U1 is displaced from the 5 0 SS by the mutually exclusive base-pairing interaction of U6 with the 5 0 SS. In the trans-splicing system used here, the 5 0 SS is directly bound by U6, as excess 5 0 SS oligo sequesters the U1 snRNP in the extract. Thus, in our trans-splicing system, U6 can apparently substitute for U1 in establishing cross-intron interactions and also in pairing the 5 0 SS and 3 0 SS, indicating that splice site pairing can potentially occur downstream of cross-intron A complex formation.
Our data demonstrate that the tri-snRNP associates already at the time of exon definition. Thus, the establishment of interactions between U2 and U1 bound to an upstream 5 0 SS (i.e., across the intron) are not a prerequisite for or must temporally precede tri-snRNP binding. Our data also indicate that the tri-snRNP can engage the 5 0 SS as part of the exon complex and that this in turn leads to the stable, apparently productive integration of the tri-snRNP (i.e., B complex formation) ( Figure 6C ). They further suggest that a cross-exon complex can be directly converted to a cross-intron B complex in which the splice sites are paired, and that the switch from a cross-exon complex to a cross-intron complex in which an upstream 5 0 SS is paired with a downstream 3 0 SS can occur without major rearrangement of the ''early'' tri-snRNP interactions that are formed in the exon-defined complex. Indeed, initial structure probing studies comparing cross-exon complexes with the 5 0 SS oligo-induced B-like complexes suggest that this transition does not involve large changes in RNP conformation ( Figure S2 and data not shown). In contrast to previous models, the cross-exon to cross-intron transition may not necessarily require the disruption of crossexon interactions between U2 and U1 at the downstream 5 0 SS.
Molecular Cell
Tri-snRNPs Associate with Cross-Exon Complexes Rather, both cross-intron and cross-exon bridging interactions could theoretically be maintained. Although the data provided here support the assembly pathway depicted in Figure 6C , they do not exclude alternative pathways for the steps occurring subsequent to exon definition. Indeed, in light of the lower cellular levels of U4, U5, and U6 relative to U1 and U2, functionally active exon complexes containing U1 and U2, but lacking tri-snRNPs, may also potentially form. Indeed, tri-snRNPs can also associate already with cross-intron A complexes formed on single intron pre-mRNAs (Maroney et al., 2000) , but functional cross-intron A complexes can nonetheless form in the absence of tri-snRNPs, indicating the existence of alternative assembly pathways for the crossintron A complex .
Implications for Regulated Splicing Events
The proposed direct conversion of an exon complex to a crossintron B complex in which the splice sites are paired has important implications for regulated splicing events. Recently, it was shown that regulation can occur at the time of stable tri-snRNP addition after exon definition. A block in the transition from cross-exon to cross-intron B complexes appears to be mediated by the RBM5 protein, which represses the inclusion of exon 6 of the apoptotic factor FAS pre-mRNA (Bonnal et al., 2008) , by PTB, which represses the inclusion of the neuron-specific N1 exon of the c-src pre-mRNA (Sharma et al., 2008) , and by hnRNP L, which prevents inclusion of exon 4 of the CD45 gene (House and Lynch, 2006) . In light of our results showing that tri-snRNPs associate with exon complexes, it is possible that in some of these cases, the specific regulatory protein involved blocks the association of the tri-snRNP with the exon complex and that this leads to a block in subsequent assembly steps. Taken together, our data suggest an alternative pathway for spliceosome assembly after initial exon definition.
EXPERIMENTAL PROCEDURES In Vitro Transcription
Templates for the MINX and b-globin exon RNAs were generated by PCR from pMINX (Zillmann et al., 1988) and the pspDupS4 series (Labourier et al., 1999) , respectively. Mutations were introduced via PCR and confirmed by sequencing. For detailed sequence information, see Figure S1 . Transcription of uniformly 32 P-labeled RNA was performed in vitro (Deckert et al., 2006) , except that m 7 G (5 0 ) ppp (5 0 ) G cap was omitted.
In Vitro Splicing Assays HeLa nuclear extract was prepared according to Dignam et al. (1983) . In vitro splicing reactions contained 40% nuclear extract, 8 mM HEPES-KOH (pH 7.9), 8% (v/v) glycerol, 0.08 mM EDTA, 0.4 mM DTE, 0.2 mM PMSF, 3 mM MgCl 2 , 65mM KCl, 2 mM ATP, 20 mM creatine phosphate, and 10 nM of 32 P-labeled pre-mRNA or exon RNA. After 2.5 min, formation of B-like complexes was induced by addition of 1 mM (final concentration) RNA oligo containing a 5 0 SS (CUGUUCAGGUAAGUAU, exonic sequence underlined), and incubation was continued for 2.5 min at 30 C (Ast et al., 2001) . Spliceosomal complexes were analyzed on agarose gels after adding heparin (final concentration of 0.1 mg/ml). For trans-splicing assays, 100 nM of exon RNA were incubated for 2.5 min at 30 C before the addition of 
MS2 Affinity Purification and Psoralen Crosslinking
Exon and B-like complexes were purified via MS2 affinity selection as described previously (Deckert et al., 2006) , with the following modifications: the final RNA concentration was 10 nM; splicing reactions were incubated for 2.5 min at 30 C; and in the case of the B-like complex, a 5 0 SS-containing RNA oligo was added and splicing was continued for an additional 2.5 min.
In vitro splicing reactions were loaded onto linear 10%-30% (v/v) glycerol gradients containing G65 buffer (20 mM HEPES-KOH [pH 7.9], 65 mM NaCl, 1.5 mM MgCl 2 ), and ultracentrifugation was performed for 130 min at 374,000 3 g in a Sorvall TH660 rotor at 4 C. The distribution of 32 P-labeled RNA was determined by Cherenkov counting, and complexes were further purified by affinity selection on an amylose Sepharose column. Unless noted otherwise, all purification steps were performed at 65 mM NaCl. RNA was recovered from the purified complexes, analyzed by denaturing PAGE, and visualized by silver staining. The stoichiometry of the snRNAs and exon RNA was determined by visual inspection of the silver-stained bands. Psoralen crosslinking of purified exon complexes, northern blotting, and generation of 32 P-labeled DNA probes were as described (Behzadnia et al., 2007) .
5
0 SS RNA Oligo-Induced Stabilization of Purified Exon Complexes
Exon complexes containing the tri-snRNP were purified via MS2 affinity selection as described above. Complexes bound to amylose beads were washed with G65 buffer. Subsequently, 2 column volumes of G65 buffer containing the 5 0 SS RNA oligo or a mutant version thereof (end concentration 10 mM)
were added, followed by incubation for 5 min at 4 C. Samples were then washed with G300 (G65 buffer with 300 mM NaCl) buffer, as indicated.
Complexes were eluted and their RNA analyzed as described above.
